Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update

Gabriel Rinnerthaler* (First author), C Singer, E Petru, D Egle, A Petzer, U Pluschnig, Simon Peter Gampenrieder (Co-author), G Pfeiler, M Gnant, B Grunberger, P Krippl, K Strasser-Weippl, C Suppan, C Brunner, R Pusch, M Sandholzer, M Balic, R Bartsch

*Corresponding author for this work

Research output: Contribution to journalOriginal Articlepeer-review

Original languageEnglish
JournalWIENER KLINISCHE WOCHENSCHRIFT
DOIs
Publication statusPublished - 2022

Keywords

  • DERUXTECAN T-DXD
  • TRASTUZUMAB-DERUXTECAN
  • OPEN-LABEL
  • PHASE-III
  • CLINICAL-PRACTICE
  • CAPECITABINE
  • PROGRESSION
  • LAPATINIB
  • CHEMOTHERAPY
  • COMBINATION

Cite this